West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Produc…
What to know about WST
West Pharmaceutical Services, Inc. is a large Healthcare company with a mixed financial profile. It scores well on health and growth, but valuation is worth keeping an eye on.
Should you consider WST?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
West Pharmaceutical Services, Inc. is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (18 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
The stock trades at a premium — investors are paying more per dollar of earnings than most S&P 500 companies. That's fine if strong growth justifies it, but leaves little room for disappointment.
-
Growth is a clear strength — revenue and earnings are expanding faster than most peers, signalling strong demand for the company's products or services.
-
There is a small dividend (0.00%), but income-focused investors will likely find better yields elsewhere in the market.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how WST compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 43.84 | Below avg |
| Forward P/E | 34.32 | Below avg |
| PEG Ratio | 3.17 | Below avg |
| Price to Sales | 7.19 | Below avg |
| Price to Book | 7.78 | Below avg |
| EV/EBITDA | 26.54 | Below avg |
| Earnings Yield | 2.28% | Below avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 36.28% | Average |
| Operating Margin | 21.70% | Above avg |
| Net Profit Margin | 16.85% | Above avg |
| Return on Equity | 19.13% | Above avg |
| Return on Invested Capital | 11.21% | Top 25% |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 21.00% | Top 25% |
| Revenue Growth (3Y CAGR) | 2.12% | Average |
| EPS Growth (YoY) | 56.10% | Top 25% |
| Free Cash Flow Growth | 69.65% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 2.71 | Top 25% |
| Debt to Equity | 0.11 | Top 25% |
| Interest Coverage | 1202.80 | Top 25% |
| Altman Z-Score | 15.70 | Top 25% |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 0.27% | Below avg |
| Payout Ratio | 11.50% | Top 25% |
| Dividend Growth (5Y) | -8.61% | Average |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 1.98% | Below avg |
| OCF to Sales | 22.21% | Above avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 1.18 | Average |
| Volatility (30-Day) | 28.71% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 3.84% | Average |
| Avg. Analyst Rating | 1.33 | Top 25% |
| Target Upside % | 9.40% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 23.17B | Average |
How does WST compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to WST — based on their financial profile.